TRAIL as biomarker and potential therapeutic tool for cardiovascular diseases. Curr Drug Targets 2012;13(9):1215-21.
. Trail down-regulates the release of osteoprotegerin (OPG) by primary stromal cells. J Cell Physiol 2011;226(9):2279-86.
. TRAIL modulates the immune system and protects against the development of diabetes. J Immunol Res 2015;2015:680749.
. TRAIL shows potential cardioprotective activity. Invest New Drugs 2012;30(3):1257-60.
. .